concentration and precipitation of dextran in the proximal tubule and the formation of casts, which obstruct the flow of tubular fluid. 
concentration and precipitation of dextran in the proximal tubule and the formation of casts, which obstruct the flow of tubular fluid. patients with the symptom) was computed to allow a comparison of the relative severity of each symptom but was not formally analysed. Forty four patients rated a non-colonic symptom as being the worst, constant lethargy, nausea, backache, and excess wind being particularly prominent; this was reflected by their severity score (table) . Some noncolonic symptoms-for example, early satietyalthough common were not ranked as particularly severe. Fifty three patients had evidence of anxiety or depression, or both. Patients with psychological symptoms tended to report more symptoms than those without, but the ranking patterns were not significantly different in the two groups.
Comment
This study confirmed the high prevalence of noncolonic symptoms in the irritable bowel syndrome and indicated that some of these can be as intrusive as the classic symptoms of abdominal pain, distension, and abnormal bowel habit. It might be argued that these findings are due to our having studied an excess of patients with psychological problems, but the prevalence of such patients in this study (53%) is in accord with previous reports.3 In addition, the ranking pattern was unaffected by the presence of psychological problems. Patients with the irritable bowel syndrome tend to be regarded as complainers. This view is not supported by our observation that the control symptom, dry skin, received by far the lowest ranking and was the least common complaint.
Some symptoms were equally common but differed considerably in their intrusiveness. Those perceived as severe may lead to inappropriate investigation. Common but less severe symptoms, such as early satiety, may be useful in discriminating the irritable bowel syndrome from other gastrointestinal disorders, and this is currently under investigation. Therapeutic trials in the irritable bowel syndrome often produce conflicting data,4 possibly because investigators fail to record non-colonic symptoms. This may also explain why overall improvement without a change in the recorded symptoms is sometimes observed.' Patients will probably cope with these disruptive symptoms better if they are reassured that they are part of their syndrome and do not have a more sinister cause.
